BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16263176)

  • 1. Can herbs provide a new generation of drugs for treating Alzheimer's disease?
    Anekonda TS; Reddy PH
    Brain Res Brain Res Rev; 2005 Dec; 50(2):361-76. PubMed ID: 16263176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglia as a potential bridge between the amyloid beta-peptide and tau.
    Kitazawa M; Yamasaki TR; LaFerla FM
    Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decade of modeling Alzheimer's disease in transgenic mice.
    McGowan E; Eriksen J; Hutton M
    Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
    Reddy PH
    J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches.
    Van Broeck B; Van Broeckhoven C; Kumar-Singh S
    Neurodegener Dis; 2007; 4(5):349-65. PubMed ID: 17622778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models.
    Reddy PH; McWeeney S
    Neurobiol Aging; 2006 Aug; 27(8):1060-77. PubMed ID: 16157420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic strategies and Alzheimer's disease: contribution of animal models].
    Chabrier PE
    Ann Pharm Fr; 2009 Mar; 67(2):97-103. PubMed ID: 19298893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Natural progression of Alzheimer's disease (AD): a perspective on possible therapies for advanced AD].
    Yanagisawa K
    Rinsho Shinkeigaku; 2004 Nov; 44(11):921-3. PubMed ID: 15651332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
    Geylis V; Steinitz M
    Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
    Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
    Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
    Gasparini L; Ongini E; Wilcock D; Morgan D
    Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylene blue and Alzheimer's disease.
    Oz M; Lorke DE; Petroianu GA
    Biochem Pharmacol; 2009 Oct; 78(8):927-32. PubMed ID: 19433072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alzheimer's disease: from brain lesions to new drugs].
    Forette F; Hauw JJ
    Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease.
    Bachurin SO
    Med Res Rev; 2003 Jan; 23(1):48-88. PubMed ID: 12424753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy as treatment for Alzheimer's disease.
    Hawkes CA; McLaurin J
    Expert Rev Neurother; 2007 Nov; 7(11):1535-48. PubMed ID: 17997702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Alzheimer's disease: from pharmacology to a better understanding of disease pathophysiology.
    Silvestrelli G; Lanari A; Parnetti L; Tomassoni D; Amenta F
    Mech Ageing Dev; 2006 Feb; 127(2):148-57. PubMed ID: 16278007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders.
    Kaplan M; Mutlu EA; Benson M; Fields JZ; Banan A; Keshavarzian A
    Complement Ther Med; 2007 Sep; 15(3):207-16. PubMed ID: 17709066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.